DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Prostate cancer invasion and metastasis: Insights from mining genomic data

Abstract

Prostate cancer (PCa) is the second most commonly diagnosed malignancy in men in the Western world and the second leading cause of cancer-related deaths among men worldwide. Although most cancers have the potential to metastasize under appropriate conditions, PCa favors the skeleton as a primary site of metastasis, suggesting that the bone microenvironment is conducive to its growth. PCa metastasis proceeds through a complex series of molecular events that include angiogenesis at the site of the original tumor, local migration within the primary site, intravasation into the blood stream, survival within the circulation, extravasation of the tumor cells to the target organ and colonization of those cells within the new site. In turn, each one of these steps involves a complicated chain of events that utilize multiple protein–protein interactions, protein signaling cascades and transcriptional changes. Despite the urgent need to improve current biomarkers for diagnosis, prognosis and drug resistance, advances have been slow. Global gene expression methods such as gene microarrays and RNA sequencing enable the study of thousands of genes simultaneously and allow scientists to examine molecular pathways of cancer pathogenesis. In this review, we summarize the current literature that explored high-throughput transcriptome analysis toward the advancement of biomarkermore » discovery for PCa. Novel biomarkers are strongly needed to enable more accurate detection of PCa, improve prediction of tumor aggressiveness and facilitate the discovery of new therapeutic targets for tailored medicine. Furthermore, promising molecular markers identified from gene expression profiling studies include HPN, CLU1, WT1, WNT5A, AURKA and SPARC.« less

Authors:
 [1];  [1];  [1]
  1. Lawrence Livermore National Lab. (LLNL), Livermore, CA (United States)
Publication Date:
Research Org.:
Lawrence Livermore National Laboratory (LLNL), Livermore, CA (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1343829
Report Number(s):
LLNL-JRNL-615633
Journal ID: ISSN 2041-2649
Grant/Contract Number:  
AC52-07NA27344
Resource Type:
Accepted Manuscript
Journal Name:
Briefings in Functional Genomics
Additional Journal Information:
Journal Volume: 12; Journal Issue: 5; Journal ID: ISSN 2041-2649
Publisher:
Oxford University Press
Country of Publication:
United States
Language:
English
Subject:
59 BASIC BIOLOGICAL SCIENCES; prostate cancer; metastasis; bone metastasis; biomarkers; microarrays; RNA-seq

Citation Formats

Hudson, Bryan D., Kulp, Kristen S., and Loots, Gabriela G. Prostate cancer invasion and metastasis: Insights from mining genomic data. United States: N. p., 2013. Web. doi:10.1093/bfgp/elt021.
Hudson, Bryan D., Kulp, Kristen S., & Loots, Gabriela G. Prostate cancer invasion and metastasis: Insights from mining genomic data. United States. https://doi.org/10.1093/bfgp/elt021
Hudson, Bryan D., Kulp, Kristen S., and Loots, Gabriela G. Mon . "Prostate cancer invasion and metastasis: Insights from mining genomic data". United States. https://doi.org/10.1093/bfgp/elt021. https://www.osti.gov/servlets/purl/1343829.
@article{osti_1343829,
title = {Prostate cancer invasion and metastasis: Insights from mining genomic data},
author = {Hudson, Bryan D. and Kulp, Kristen S. and Loots, Gabriela G.},
abstractNote = {Prostate cancer (PCa) is the second most commonly diagnosed malignancy in men in the Western world and the second leading cause of cancer-related deaths among men worldwide. Although most cancers have the potential to metastasize under appropriate conditions, PCa favors the skeleton as a primary site of metastasis, suggesting that the bone microenvironment is conducive to its growth. PCa metastasis proceeds through a complex series of molecular events that include angiogenesis at the site of the original tumor, local migration within the primary site, intravasation into the blood stream, survival within the circulation, extravasation of the tumor cells to the target organ and colonization of those cells within the new site. In turn, each one of these steps involves a complicated chain of events that utilize multiple protein–protein interactions, protein signaling cascades and transcriptional changes. Despite the urgent need to improve current biomarkers for diagnosis, prognosis and drug resistance, advances have been slow. Global gene expression methods such as gene microarrays and RNA sequencing enable the study of thousands of genes simultaneously and allow scientists to examine molecular pathways of cancer pathogenesis. In this review, we summarize the current literature that explored high-throughput transcriptome analysis toward the advancement of biomarker discovery for PCa. Novel biomarkers are strongly needed to enable more accurate detection of PCa, improve prediction of tumor aggressiveness and facilitate the discovery of new therapeutic targets for tailored medicine. Furthermore, promising molecular markers identified from gene expression profiling studies include HPN, CLU1, WT1, WNT5A, AURKA and SPARC.},
doi = {10.1093/bfgp/elt021},
journal = {Briefings in Functional Genomics},
number = 5,
volume = 12,
place = {United States},
year = {Mon Jul 22 00:00:00 EDT 2013},
month = {Mon Jul 22 00:00:00 EDT 2013}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 27 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

MUC1 enhances invasiveness of pancreatic cancer cells by inducing epithelial to mesenchymal transition
journal, November 2010


Promising tumor-associated antigens for future prostate cancer therapy: TAAs AS POTENTIAL THERAPEUTIC TARGETS
journal, June 2009

  • Li, Yong; Cozzi, Paul J.; Russell, Pamela J.
  • Medicinal Research Reviews, Vol. 30, Issue 1
  • DOI: 10.1002/med.20165

RNA Interference-directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity in Vivo
journal, August 2005

  • Pulukuri, Sai MuraliKrishna; Gondi, Christopher S.; Lakka, Sajani S.
  • Journal of Biological Chemistry, Vol. 280, Issue 43
  • DOI: 10.1074/jbc.M503111200

Profiling and Verification of Gene Expression Patterns in Normal and Malignant Human Prostate Tissues by cDNA Microarray Analysis
journal, January 2001


Gene expression profiling identifies clinically relevant subtypes of prostate cancer
journal, January 2004

  • Lapointe, J.; Li, C.; Higgins, J. P.
  • Proceedings of the National Academy of Sciences, Vol. 101, Issue 3
  • DOI: 10.1073/pnas.0304146101

Influence of MUC1 genetic variation on prostate cancer risk and survival
journal, July 2008

  • Strawbridge, Rona J.; Nister, Monica; Brismar, Kerstin
  • European Journal of Human Genetics, Vol. 16, Issue 12
  • DOI: 10.1038/ejhg.2008.131

A Prognostic Gene Expression Profile That Predicts Circulating Tumor Cell Presence in Breast Cancer Patients
journal, February 2012


The Role of SPINK1 in ETS Rearrangement-Negative Prostate Cancers
journal, June 2008


Gene therapy for cancer and metastatic disease
journal, June 2003

  • Kesmodel, Susan B.; Spitz, Francis R.
  • Expert Reviews in Molecular Medicine, Vol. 5, Issue 17
  • DOI: 10.1017/S1462399403006380

Decrease and Gain of Gene Expression Are Equally Discriminatory Markers for Prostate Carcinoma
journal, June 2002


Elevated Level of Wnt5a Protein in Localized Prostate Cancer Tissue Is Associated with Better Outcome
journal, October 2011


Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts
journal, January 2011

  • Shiirevnyamba, A.; Takahashi, T.; Shan, H.
  • British Journal of Cancer, Vol. 104, Issue 3
  • DOI: 10.1038/sj.bjc.6606070

Gene expression analysis of prostate cancers
journal, January 2002

  • Luo, Jian-Hua; Yu, Yan Ping; Cieply, Kathleen
  • Molecular Carcinogenesis, Vol. 33, Issue 1
  • DOI: 10.1002/mc.10018

Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion
journal, January 2012


Circulating tumour cell (CTC) counts as intermediate end points in castration-resistant prostate cancer (CRPC): a single-centre experience
journal, January 2009


Modulation of prostate cancer cell gene expression by cell-to-cell contact with bone marrow stromal cells or osteoblasts
journal, September 2009

  • Zhang, Shuming; Wang, Jun; Bilen, Mehmet A.
  • Clinical & Experimental Metastasis, Vol. 26, Issue 8
  • DOI: 10.1007/s10585-009-9289-0

Regulation of a Late Phase of T Cell Polarity and Effector Functions by Crtam
journal, March 2008


Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN-mutated prostate cancer cells
journal, January 2005

  • Ohigashi, T.; Mizuno, R.; Nakashima, J.
  • The Prostate, Vol. 62, Issue 1
  • DOI: 10.1002/pros.20117

Interleukin-6 Polymorphism is Associated with more Aggressive Prostate Cancer
journal, August 2005


CEA-related cell adhesion molecule-1 is involved in angiogenic switch in prostate cancer
journal, March 2006


Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis
journal, June 2003

  • Fu, Z.; Smith, P. C.; Zhang, L.
  • JNCI Journal of the National Cancer Institute, Vol. 95, Issue 12
  • DOI: 10.1093/jnci/95.12.878

Cancer statistics, 2012
journal, January 2012

  • Siegel, Rebecca; Naishadham, Deepa; Jemal, Ahmedin
  • CA: A Cancer Journal for Clinicians, Vol. 62, Issue 1
  • DOI: 10.3322/caac.20138

Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression
journal, August 2011

  • Prensner, John R.; Iyer, Matthew K.; Balbin, O. Alejandro
  • Nature Biotechnology, Vol. 29, Issue 8
  • DOI: 10.1038/nbt.1914

Basal prostate epithelial cells stimulate the migration of prostate cancer cells
journal, January 2004

  • Yu, Hsiao-Man; Frank, Diane E.; Zhang, Jie
  • Molecular Carcinogenesis, Vol. 41, Issue 2
  • DOI: 10.1002/mc.20041

Role of prostaglandin E produced by osteoblasts in osteolysis due to bone metastasis
journal, January 2003

  • Ohshiba, Tomoyasu; Miyaura, Chisato; Ito, Akira
  • Biochemical and Biophysical Research Communications, Vol. 300, Issue 4
  • DOI: 10.1016/S0006-291X(02)02937-6

Altered expression of the WT1 Wilms tumor suppressor gene in human breast cancer
journal, July 1997

  • Silberstein, G. B.; Van Horn, K.; Strickland, P.
  • Proceedings of the National Academy of Sciences, Vol. 94, Issue 15
  • DOI: 10.1073/pnas.94.15.8132

Effect of bisphosphonates on pain and quality of life in patients with bone metastases
journal, February 2009

  • Costa, Luis; Major, Pierre P.
  • Nature Reviews Clinical Oncology, Vol. 6, Issue 3
  • DOI: 10.1038/ncponc1323

Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase
journal, January 2010


SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor–stromal interactions
journal, August 2003

  • Sato, Norihiro; Fukushima, Noriyoshi; Maehara, Naoki
  • Oncogene, Vol. 22, Issue 32
  • DOI: 10.1038/sj.onc.1206807

Treatment and prevention of bone complications from prostate cancer
journal, January 2011


Both osteopontin-c and osteopontin-b splicing isoforms exert pro-tumorigenic roles in prostate cancer cells
journal, April 2012

  • Tilli, Tatiana M.; Mello, Kivvi D.; Ferreira, Luciana B.
  • The Prostate, Vol. 72, Issue 15
  • DOI: 10.1002/pros.22523

A novel approach using telomerase-specific replication-selective adenovirus for detection of circulating tumor cells in breast cancer patients
journal, June 2011

  • Kim, Seung Jin; Masago, Akinori; Tamaki, Yasuhiro
  • Breast Cancer Research and Treatment, Vol. 128, Issue 3
  • DOI: 10.1007/s10549-011-1603-2

Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer: Sp/KLF Family in Cell Growth and Cancer
journal, June 2001

  • Black, Adrian R.; Black, Jennifer D.; Azizkhan-Clifford, Jane
  • Journal of Cellular Physiology, Vol. 188, Issue 2
  • DOI: 10.1002/jcp.1111

Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.
journal, November 1994

  • Lee, W. H.; Morton, R. A.; Epstein, J. I.
  • Proceedings of the National Academy of Sciences, Vol. 91, Issue 24
  • DOI: 10.1073/pnas.91.24.11733

Use of Desmin Immunohistochemistry To Distinguish Between Mesothelial Cells and Carcinoma in Serous Fluid Cell Block Preparations
journal, January 2000

  • Gill, Stephen A.; Meier, P. A.; Kendall, Brian S.
  • Acta Cytologica, Vol. 44, Issue 6
  • DOI: 10.1159/000328619

Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells
journal, December 2012

  • Gravina, Giovanni Luca; Ranieri, Guido; Muzi, Paola
  • Oncology Reports, Vol. 29, Issue 3
  • DOI: 10.3892/or.2012.2192

55 kDa nuclear matrix protein (nmt55) mRNA is expressed in human prostate cancer tissue and is associated with the androgen receptor
journal, May 2003

  • Ishiguro, Hitoshi; Uemura, Hiroji; Fujinami, Kiyoshi
  • International Journal of Cancer, Vol. 105, Issue 1
  • DOI: 10.1002/ijc.11021

A multimarker QPCR-based platform for the detection of circulating tumour cells in patients with early-stage breast cancer
journal, May 2011

  • Molloy, T. J.; Devriese, L. A.; Helgason, H. H.
  • British Journal of Cancer, Vol. 104, Issue 12
  • DOI: 10.1038/bjc.2011.164

Tyrosine-phosphorylated Galectin-3 Protein Is Resistant to Prostate-specific Antigen (PSA) Cleavage
journal, January 2012

  • Balan, Vitaly; Nangia-Makker, Pratima; Kho, Dhong Hyo
  • Journal of Biological Chemistry, Vol. 287, Issue 8
  • DOI: 10.1074/jbc.C111.331686

Novel Molecular Targets for the Therapy of Castration-Resistant Prostate Cancer
journal, May 2012


Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma
journal, June 2010

  • Palanisamy, Nallasivam; Ateeq, Bushra; Kalyana-Sundaram, Shanker
  • Nature Medicine, Vol. 16, Issue 7
  • DOI: 10.1038/nm.2166

Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival
journal, December 2002

  • Sfiligoi, Christian; de Luca, Annarita; Cascone, Ilaria
  • International Journal of Cancer, Vol. 103, Issue 4
  • DOI: 10.1002/ijc.10851

Delineation of prognostic biomarkers in prostate cancer
journal, August 2001

  • Dhanasekaran, Saravana M.; Barrette, Terrence R.; Ghosh, Debashis
  • Nature, Vol. 412, Issue 6849
  • DOI: 10.1038/35090585

Genomic Structure and DNA Binding Properties of the Human Zinc Finger Transcriptional Repressor AP-2rep (KLF12)
journal, February 2000


MUC1 is a Promising Therapeutic Target for Prostate Cancer Therapy
journal, May 2007


FGFR1 and WT1 are markers of human prostate cancer progression
journal, November 2006


Role of proteolytic enzymes in human prostate bone metastasis formation: in vivo and in vitro studies
journal, April 2002

  • Hart, C. A.; Scott, L. J.; Bagley, S.
  • British Journal of Cancer, Vol. 86, Issue 7
  • DOI: 10.1038/sj.bjc.6600207

Immunohistochemical detection of WT1 protein in a variety of cancer cells
journal, March 2006


Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro
journal, January 2001

  • Lin, Din-Lii; Tarnowski, Catherine P.; Zhang, Jian
  • The Prostate, Vol. 47, Issue 3
  • DOI: 10.1002/pros.1065

mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: Valuable tool for risk assessment and prevention trials
journal, February 2010

  • Nonn, Larisa; Vaishnav, Avani; Gallagher, Lindsay
  • Experimental and Molecular Pathology, Vol. 88, Issue 1
  • DOI: 10.1016/j.yexmp.2009.10.005

Fluorescence In situ Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer
journal, March 2009


Prostate Cancer-Associated Gene Expression Alterations Determined from Needle Biopsies
journal, April 2009


A causal role for ERG in neoplastic transformation of prostate epithelium
journal, February 2008

  • Klezovitch, O.; Risk, M.; Coleman, I.
  • Proceedings of the National Academy of Sciences, Vol. 105, Issue 6
  • DOI: 10.1073/pnas.0711711105

WT1 gene expression as a prognostic marker in advanced serous epithelial ovarian carcinoma: an immunohistochemical study
journal, April 2006

  • Netinatsunthorn, Wirote; Hanprasertpong, Jitti; Dechsukhum, Chavaboon
  • BMC Cancer, Vol. 6, Issue 1
  • DOI: 10.1186/1471-2407-6-90

Inhibition of Prostate Cancer Bone Metastasis by Synthetic TF Antigen Mimic/Galectin-3 Inhibitor Lactulose-l-Leucine
journal, January 2012

  • Glinskii, Olga V.; Sud, Sudha; Mossine, Valeri V.
  • Neoplasia, Vol. 14, Issue 1
  • DOI: 10.1593/neo.111544

Laser-capture microdissection in prostate cancer research: establishment and validation of a powerful tool for the assessment of tumour–stroma interactions
journal, March 2008


Targeted next-generation sequencing of a cancer transcriptome enhances detection of sequence variants and novel fusion transcripts
journal, January 2009


A Role for the G 12 Family of Heterotrimeric G Proteins in Prostate Cancer Invasion
journal, June 2006

  • Kelly, Patrick; Stemmle, Laura N.; Madden, John F.
  • Journal of Biological Chemistry, Vol. 281, Issue 36
  • DOI: 10.1074/jbc.M604376200

Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation
journal, January 2009


Analysis of gene expression in prostate cancer epithelial and interstitial stromal cells using laser capture microdissection
journal, April 2010


SPARC Inhibits LPA-Mediated Mesothelial—Ovarian Cancer Cell Crosstalk
journal, January 2007

  • Said, Neveen A.; Najwer, Ida; Socha, Matthew J.
  • Neoplasia, Vol. 9, Issue 1
  • DOI: 10.1593/neo.06658

A Diagnostic Test for Prostate Cancer From Gene Expression Profiling Data
journal, February 2004


Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
journal, May 2012

  • Barbieri, Christopher E.; Baca, Sylvan C.; Lawrence, Michael S.
  • Nature Genetics, Vol. 44, Issue 6
  • DOI: 10.1038/ng.2279

Genetic determinants of cancer metastasis
journal, May 2007

  • Nguyen, Don X.; Massagué, Joan
  • Nature Reviews Genetics, Vol. 8, Issue 5
  • DOI: 10.1038/nrg2101

Molecular characterization of circulating tumor cells in patients with ovarian cancer improves their prognostic significance — A study of the OVCAD consortium
journal, January 2013


Global Gene Expression Analysis of Reactive Stroma in Prostate Cancer
journal, June 2009


The urokinase-type plasminogen activator system in cancer metastasis: A review
journal, July 1997


Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice
journal, March 2006

  • Angelucci, Adriano; Gravina, Giovanni Luca; Rucci, Nadia
  • Endocrine-Related Cancer
  • DOI: 10.1677/erc.1.01100

Growth differentiation factor-15 upregulates interleukin-6 to promote tumorigenesis of prostate carcinoma PC-3 cells
journal, August 2012

  • Tsui, Ke-Hung; Chang, Ying-Ling; Feng, Tsui-Hsia
  • Journal of Molecular Endocrinology, Vol. 49, Issue 2
  • DOI: 10.1530/JME-11-0149

Genome-wide Profiling of RNA splicing in prostate tumor from RNA-seq data using virtual microarrays
journal, January 2012

  • Srinivasan, Subhashini; Patil, Arun H.; Verma, Mohit
  • Journal of Clinical Bioinformatics, Vol. 2, Issue 1
  • DOI: 10.1186/2043-9113-2-21

Co-evolution of tumor cells and their microenvironment
journal, January 2009


MUC1 as a Putative Prognostic Marker for Prostate Cancer
journal, January 2008

  • Strawbridge, Rona J.; Nistér, Monica; Brismar, Kerstin
  • Biomarker Insights, Vol. 3
  • DOI: 10.4137/BMI.S666

TGF-β1 Reverses Inhibition of COX-2 With NS398 and Increases Invasion in Prostate Cancer Cells
journal, May 2010

  • Ding, Qiang; Bai, Yu-Feng; Wang, Yong-Quan
  • The American Journal of the Medical Sciences, Vol. 339, Issue 5
  • DOI: 10.1097/MAJ.0b013e3181d7c9db

Significance of overexpression of alpha methylacyl-coenzyme A racemase in hepatocellular carcinoma
journal, May 2008

  • Li, Wei; Cagle, Philip T.; Botero, Rafael C.
  • Journal of Experimental & Clinical Cancer Research, Vol. 27, Issue 1
  • DOI: 10.1186/1756-9966-27-2

MUC1, MUC2, MUC4, MUC5AC and MUC6 Expression in the Progression of Prostate Cancer
journal, November 2005

  • Cozzi, Paul J.; Wang, Jian; Delprado, Warick
  • Clinical & Experimental Metastasis, Vol. 22, Issue 7
  • DOI: 10.1007/s10585-005-5376-z

Molecular mechanisms of metastasis in prostate cancer
journal, December 2008

  • Clarke, Noel W.; Hart, Claire A.; Brown, Mick D.
  • Asian Journal of Andrology, Vol. 11, Issue 1
  • DOI: 10.1038/aja.2008.29

Steps in prostate cancer progression that lead to bone metastasis
journal, March 2011

  • Jin, Jung-Kang; Dayyani, Farshid; Gallick, Gary E.
  • International Journal of Cancer, Vol. 128, Issue 11
  • DOI: 10.1002/ijc.26024

Influence of Surgical Manipulation on Prostate Gene Expression: Implications for Molecular Correlates of Treatment Effects and Disease Prognosis
journal, August 2006

  • Lin, Daniel W.; Coleman, Ilsa M.; Hawley, Sarah
  • Journal of Clinical Oncology, Vol. 24, Issue 23
  • DOI: 10.1200/JCO.2005.05.1458

Oncoproteomic Analysis Reveals Co-Upregulation of RELA and STAT5 in Carboplatin Resistant Ovarian Carcinoma
journal, June 2010


Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines
journal, December 2002


Targeting Aurora Kinases for the Treatment of Prostate Cancer
journal, May 2006


RECK overexpression decreases invasive potential in prostate cancer cells
journal, October 2011

  • Rabien, Anja; Ergün, Bettina; Erbersdobler, Andreas
  • The Prostate, Vol. 72, Issue 9
  • DOI: 10.1002/pros.21498

MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines
journal, April 2011

  • Viticchiè, Giuditta; Lena, Anna Maria; Latina, Alessia
  • Cell Cycle, Vol. 10, Issue 7
  • DOI: 10.4161/cc.10.7.15180

Evaluation of urokinase plasminogen activator and its receptor in different grades of human prostate cancer☆
journal, November 2006


Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
journal, May 2013


Genomic Alterations Indicate Tumor Origin and Varied Metastatic Potential of Disseminated Cells from Prostate Cancer Patients
journal, July 2008


High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma
journal, September 2007


Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models
journal, October 2012

  • Becker-Santos, D. D.; Guo, Y.; Ghaffari, M.
  • Carcinogenesis, Vol. 33, Issue 12
  • DOI: 10.1093/carcin/bgs285

Differential Gene Expression in Benign Prostate Epithelium of Men with and without Prostate Cancer: Evidence for a Prostate Cancer Field Effect
journal, October 2010


Suppression of Prostate Carcinoma Cell Invasion by Expression of Antisense L-Plastin Gene
journal, July 1999

  • Zheng, Jianping; Rudra-Ganguly, Nandini; Powell, William C.
  • The American Journal of Pathology, Vol. 155, Issue 1
  • DOI: 10.1016/S0002-9440(10)65106-1

Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing
journal, October 2010


The translational landscape of mTOR signalling steers cancer initiation and metastasis
journal, February 2012

  • Hsieh, Andrew C.; Liu, Yi; Edlind, Merritt P.
  • Nature, Vol. 485, Issue 7396
  • DOI: 10.1038/nature10912

Downregulation of several fibulin genes in prostate cancer
journal, January 2007

  • Wlazlinski, Agnes; Engers, Rainer; Hoffmann, Michèle J.
  • The Prostate, Vol. 67, Issue 16
  • DOI: 10.1002/pros.20667

Molecular Pathways Involved in Prostate Carcinogenesis: Insights from Public Microarray Datasets
journal, November 2012


Integrative analysis of the melanoma transcriptome
journal, February 2010

  • Berger, M. F.; Levin, J. Z.; Vijayendran, K.
  • Genome Research, Vol. 20, Issue 4
  • DOI: 10.1101/gr.103697.109

Modulation of the receptor for urokinase-type plasminogen activator in macrophage-like U937 cells by inflammatory mediators
journal, June 1996

  • Yoshida, Etsuo; Tsuchiya, Kimiyuki; Sugiki, Masahiko
  • Inflammation, Vol. 20, Issue 3
  • DOI: 10.1007/BF01488206

A functional thrombin receptor (PAR1) is expressed on bone-derived prostate cancer cell lines
journal, November 2002


Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients
journal, December 2010


Isolation of rare circulating tumour cells in cancer patients by microchip technology
journal, December 2007

  • Nagrath, Sunitha; Sequist, Lecia V.; Maheswaran, Shyamala
  • Nature, Vol. 450, Issue 7173
  • DOI: 10.1038/nature06385

Looking Beyond Morphology: Cancer Gene Expression Profiling Using DNA Microarrays
journal, January 2003

  • Luo, Jun; Isaacs, William B.; Trent, Jeffrey M.
  • Cancer Investigation, Vol. 21, Issue 6
  • DOI: 10.1081/CNV-120025096

The “seed and soil” hypothesis revisited
journal, August 2008


A comparison of analog and Next-Generation transcriptomic tools for mammalian studies
journal, March 2011

  • Roy, N. C.; Altermann, E.; Park, Z. A.
  • Briefings in Functional Genomics, Vol. 10, Issue 3
  • DOI: 10.1093/bfgp/elr005

The Wilms’ tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells
journal, January 2013


Clusterin Mediates TGF- -Induced Epithelial-Mesenchymal Transition and Metastasis via Twist1 in Prostate Cancer Cells
journal, August 2012


Caveolin-1 Expression Inhibits Wnt/β-Catenin/Lef-1 Signaling by Recruiting β-Catenin to Caveolae Membrane Domains
journal, May 2000

  • Galbiati, Ferruccio; Volonte', Daniela; Brown, Anthony M. C.
  • Journal of Biological Chemistry, Vol. 275, Issue 30
  • DOI: 10.1074/jbc.M002020200

Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells
journal, August 2011

  • Tsui, Ke-Hung; Chung, Li-Chuan; Feng, Tsui-Hsia
  • International Journal of Cancer, Vol. 130, Issue 12
  • DOI: 10.1002/ijc.26284

Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases
journal, October 2007

  • Morrissey, Colm; True, Lawrence D.; Roudier, Martine P.
  • Clinical & Experimental Metastasis, Vol. 25, Issue 4
  • DOI: 10.1007/s10585-007-9116-4

Serum Level of Clusterin and Its Density in Men with Prostate Cancer as Novel Biomarkers Reflecting Disease Extension
journal, February 2010


Transcriptome sequencing to detect gene fusions in cancer
journal, January 2009

  • Maher, Christopher A.; Kumar-Sinha, Chandan; Cao, Xuhong
  • Nature, Vol. 458, Issue 7234
  • DOI: 10.1038/nature07638

Innate immunity in early chordates and the appearance of adaptive immunity
journal, June 2004


N-myc Downstream Regulated Gene 1 (NDRG1) Is Fused to ERG in Prostate Cancer
journal, August 2009

  • Pflueger, Dorothee; Rickman, David S.; Sboner, Andrea
  • Neoplasia, Vol. 11, Issue 8
  • DOI: 10.1593/neo.09572

Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
journal, May 2012


Metastasis: recent discoveries and novel treatment strategies
journal, May 2007


Regulation of Osteoclast Differentiation
journal, April 2006


RECK—a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer
journal, September 2007

  • Clark, Jonathan C. M.; Thomas, David M.; Choong, Peter F. M.
  • Cancer and Metastasis Reviews, Vol. 26, Issue 3-4
  • DOI: 10.1007/s10555-007-9093-8

Blood-Based Biomarkers of Aggressive Prostate Cancer
journal, September 2012


SPARC stimulates the synthesis of OPG/OCIF, MMP-2 and DNA in human periodontal ligament cells: SPARC actions on periodontal ligament cells
journal, July 2002


The Multifaceted Roles of Osteopontin in Cell Signaling, Tumor Progression and Angiogenesis
journal, December 2006


Immunohistochemical Analysis of Nuclear Versus Cytoplasmic Staining of WT1 in Malignant Mesotheliomas and Primary Pulmonary Adenocarcinomas
journal, October 2001

  • Foster, Matthew R.; Johnson, Joyce E.; Olson, Sandy J.
  • Archives of Pathology & Laboratory Medicine, Vol. 125, Issue 10
  • DOI: 10.5858/2001-125-1316-IAONVC

The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells
journal, October 2009

  • Morrissey, Colm; Lai, Janice S.; Brown, Lisha G.
  • The Prostate, Vol. 70, Issue 4
  • DOI: 10.1002/pros.21075

Works referencing / citing this record:

MiR-223-3p targeting SEPT6 promotes the biological behavior of prostate cancer
journal, December 2014

  • Wei, Yongbao; Yang, Jinrui; Yi, Lu
  • Scientific Reports, Vol. 4, Issue 1
  • DOI: 10.1038/srep07546

Trends in Gene Expression Profiling for Prostate Cancer Risk Assessment: A Systematic Review
journal, May 2017

  • Chen, Zhaoyi; Gerke, Travis; Bird, Victoria
  • Biomedicine Hub, Vol. 2, Issue 2
  • DOI: 10.1159/000472146

Renal and retroperitoneal metastasis from prostate adenocarcinoma: a case report
journal, March 2016


Notch1 suppresses prostate cancer cell invasion via the metastasis-associated 1-KiSS-1 metastasis-suppressor pathway
journal, August 2017

  • Deng, Gang; Zheng, Xiaoliang; Jiang, Peiwu
  • Oncology Letters, Vol. 14, Issue 4
  • DOI: 10.3892/ol.2017.6761

Trends in Gene Expression Profiling for Prostate Cancer Risk Assessment: A Systematic Review
journal, May 2017

  • Chen, Zhaoyi; Gerke, Travis; Bird, Victoria
  • Biomedicine Hub, Vol. 2, Issue 2
  • DOI: 10.1159/000472146

Novel Tools for Prostate Cancer Prognosis, Diagnosis, and Follow-Up
journal, January 2014

  • Dimakakos, Andreas; Armakolas, Athanasios; Koutsilieris, Michael
  • BioMed Research International, Vol. 2014
  • DOI: 10.1155/2014/890697